Central airway administration for systemic delivery of therapeutics

Details for Australian Patent Application No. 2002316574 (hide)

Owner The Brigham and Women's Hospital, Inc. Children's Medical Center Corporation Syntonix Pharmaceuticals, Inc. Brandeis University

Inventors Blumberg, Richard S; Lencer, Wayne I; Bitonti, Alan J; Simister, Neil E

Agent Pizzeys

Pub. Number AU-B-2002316574

PCT Number PCT/US02/21335

PCT Pub. Number WO2003/077834

Priority 60/364,482 15.03.02 US

Filing date 3 July 2002

Wipo publication date 29 September 2003

Acceptance publication date 1 May 2008

International Classifications

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/24 (2006.01) Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 5/10 (2006.01) Drugs for disorders of the endocrine system

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 60/364,482 15.03.02 US

6 November 2003 Application Open to Public Inspection

  Published as AU-B-2002316574

30 June 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from The Brigham and Women's Hospital, Inc. to The Brigham and Women's Hospital, Inc., Children's Medical Center Corporation, Syntonix Pharmaceuticals, Inc., Brandeis University

1 May 2008 Application Accepted

  Published as AU-B-2002316574

28 August 2008 Standard Patent Sealed

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002316575-MICROORGANISMS AND PROCESSES FOR ENHANCED PRODUCTION OF PANTOTHENATE

2002316573-2-(5-(5-CARBAMIMIDOYL-1H-HETER OARYL)-6-HYDROXYBIPHENYL-3-YL) -SUCCINIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS